Literature DB >> 10950801

Effects of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-gamma mRNA accumulation and protein secretion.

J L Joyner1, N H Augustine, K A Taylor, T R La Pine, H R Hill.   

Abstract

Group B streptococci (GBS) are a major cause of early-onset infection in neonates. Neonates, who have defects in neutrophil function that likely contribute to susceptibility to GBS infection, are deficient in the production of the phagocyte activator interferon (IFN)-gamma. GBS-stimulated mRNA accumulation and protein secretion of IFN-gamma and interleukin (IL)-12, a major enhancer of IFN-gamma production, by mixed mononuclear cells (MMCs) from umbilical cord and adult peripheral blood was examined. GBS-exposed cord blood MMCs secreted lower concentrations of both IL-12 and IFN-gamma proteins than did MMCs from adults. IL-12 and IFN-gamma mRNA accumulation was examined by use of comparative reverse transcriptase-polymerase chain reaction. Cord blood MMCs accumulated less mRNA for both IL-12 and IFN-gamma than did adult blood MMC. The deficiency in cord blood cell production of IL-12 may have a role in inadequate IFN-gamma production, which contributes to the unique susceptibility of neonates to GBS infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950801     DOI: 10.1086/315796

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma.

Authors:  L Maródi; K Goda; A Palicz; G Szabó
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Down-regulation of Th1 responses in human neonates.

Authors:  L Marodi
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Development of interleukin-12-producing capacity throughout childhood.

Authors:  John W Upham; Peter T Lee; Barbara J Holt; Tricia Heaton; Susan L Prescott; Mary J Sharp; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 4.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Cytokine responses to group B streptococci induce nitric oxide production in respiratory epithelial cells.

Authors:  Kenneth J Goodrum; Jane Poulson-Dunlap
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora.

Authors:  Helen Karlsson; Christina Hessle; Anna Rudin
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells.

Authors:  Mingyong Wang; Yue Chen; Yani Zhang; Liyun Zhang; Xiao Lu; Zhengliang Chen
Journal:  Cell Mol Immunol       Date:  2011-03-07       Impact factor: 11.530

8.  Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus.

Authors:  Andrew J Currie; Samantha Curtis; Tobias Strunk; Karen Riley; Khemanganee Liyanage; Susan Prescott; Dorota Doherty; Karen Simmer; Peter Richmond; David Burgner
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

9.  Critical role of the complement system in group B streptococcus-induced tumor necrosis factor alpha release.

Authors:  Ofer Levy; Rochelle M Jean-Jacques; Colette Cywes; Richard B Sisson; Kol A Zarember; Paul J Godowski; Jennifer L Christianson; Hilde-Kari Guttormsen; Michael C Carroll; Anne Nicholson-Weller; Michael R Wessels
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Neonatal innate TLR-mediated responses are distinct from those of adults.

Authors:  Tobias R Kollmann; Juliet Crabtree; Annie Rein-Weston; Darren Blimkie; Francis Thommai; Xiu Yu Wang; Pascal M Lavoie; Jeff Furlong; Edgardo S Fortuno; Adeline M Hajjar; Natalie R Hawkins; Steven G Self; Christopher B Wilson
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.